These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1338 related items for PubMed ID: 10592406

  • 1. The use of itraconazole to treat cutaneous fungal infections in children.
    Gupta AK, Nolting S, de Prost Y, Delescluse J, Degreef H, Theissen U, Wallace R, Marynissen G, De Doncker P.
    Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
    [Abstract] [Full Text] [Related]

  • 2. Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview.
    Doncker PD, Gupta AK, Marynissen G, Stoffels P, Heremans A.
    J Am Acad Dermatol; 1997 Dec; 37(6):969-74. PubMed ID: 9418766
    [Abstract] [Full Text] [Related]

  • 3. Update in antifungal therapy of dermatophytosis.
    Gupta AK, Cooper EA.
    Mycopathologia; 2008 Dec; 166(5-6):353-67. PubMed ID: 18478357
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK, Gregurek-Novak T.
    Dermatology; 2001 Dec; 202(3):235-8. PubMed ID: 11385230
    [Abstract] [Full Text] [Related]

  • 5. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole.
    Möhrenschlager M, Schnopp C, Fesq H, Strom K, Beham A, Mempel M, Thomsen S, Brockow K, Wessner DB, Heidelberger A, Ruhdorfer S, Weigl L, Seidl HP, Ring J, Abeck D.
    Br J Dermatol; 2000 Nov; 143(5):1011-5. PubMed ID: 11069511
    [Abstract] [Full Text] [Related]

  • 6. Terbinafine. An update of its use in superficial mycoses.
    McClellan KJ, Wiseman LR, Markham A.
    Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
    [Abstract] [Full Text] [Related]

  • 7. Itraconazole is effective in the treatment of tinea capitis caused by Microsporum canis.
    Gupta AK, Ginter G.
    Pediatr Dermatol; 2001 Jul; 18(6):519-22. PubMed ID: 11841643
    [Abstract] [Full Text] [Related]

  • 8. Systemic antifungal therapy for tinea capitis in children.
    Chen X, Jiang X, Yang M, González U, Lin X, Hua X, Xue S, Zhang M, Bennett C.
    Cochrane Database Syst Rev; 2016 May 12; 2016(5):CD004685. PubMed ID: 27169520
    [Abstract] [Full Text] [Related]

  • 9. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
    Mock M, Monod M, Baudraz-Rosselet F, Panizzon RG.
    Dermatology; 1998 May 12; 197(4):361-7. PubMed ID: 9873175
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
    Gupta AK, Adam P, Dlova N, Lynde CW, Hofstader S, Morar N, Aboobaker J, Summerbell RC.
    Pediatr Dermatol; 2001 May 12; 18(5):433-8. PubMed ID: 11737692
    [Abstract] [Full Text] [Related]

  • 11. Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up.
    Tosti A, Piraccini BM, Stinchi C, Colombo MD.
    Dermatology; 1998 May 12; 197(2):162-6. PubMed ID: 9732167
    [Abstract] [Full Text] [Related]

  • 12. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
    Filho ST, Cucé LC, Foss NT, Marques SA, Santamaria JR.
    J Eur Acad Dermatol Venereol; 1998 Sep 12; 11(2):141-6. PubMed ID: 9784040
    [Abstract] [Full Text] [Related]

  • 13. Treatment of tinea capitis with itraconazole capsule pulse therapy.
    Gupta AK, Hofstader SL, Summerbell RC, Solomon R, Adam P, Alexis M, Raboobee N, De Doncker P.
    J Am Acad Dermatol; 1998 Aug 12; 39(2 Pt 1):216-9. PubMed ID: 9704832
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of the efficacy of oral fluconazole, 150 mg/week versus 50 mg/day, in the treatment of tinea corporis, tinea cruris, tinea pedis, and cutaneous candidosis.
    Nozickova M, Koudelkova V, Kulikova Z, Malina L, Urbanowski S, Silny W.
    Int J Dermatol; 1998 Sep 12; 37(9):703-5. PubMed ID: 9762826
    [No Abstract] [Full Text] [Related]

  • 16. The changing face of Microsporum spp infections.
    Skerlev M, Miklić P.
    Clin Dermatol; 2010 Mar 04; 28(2):146-50. PubMed ID: 20347656
    [Abstract] [Full Text] [Related]

  • 17. Fungus isolated from dermatomycoses: a 9-month prospective study at Hospital Melaka.
    Ng LC, Lee CS, Lim BB, Mohd Tap R, Tan XT, Tang MM.
    Med J Malaysia; 2023 May 04; 78(3):364-371. PubMed ID: 37271847
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of itraconazole pulse therapy: Brazilian multicentric study on toenail onychomycosis caused by dermatophytes.
    Ramos-e-Silva M, Marques SA, Gontijo B, Zaitz C, Campbell I, Veloso ST.
    J Eur Acad Dermatol Venereol; 1998 Sep 04; 11(2):109-16. PubMed ID: 9784035
    [Abstract] [Full Text] [Related]

  • 19. Case Report: Itraconazole Oral Solution Continuous Therapy for Infantile Tinea Capitis.
    Zhou YB, Chao JJ, Ma L, Xiao YY.
    Am J Trop Med Hyg; 2024 May 01; 110(5):965-967. PubMed ID: 38531098
    [Abstract] [Full Text] [Related]

  • 20. A U.S. epidemiologic survey of superficial fungal diseases.
    Kemna ME, Elewski BE.
    J Am Acad Dermatol; 1996 Oct 01; 35(4):539-42. PubMed ID: 8859279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.